Isaac Barchas
CIK: 0001808343
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Immunome Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Aug 12, 2026IMNM
Immunome Inc.
Sale(S)Direct11K shares at avg. $27.25$301K - Aug 11, 2026IMNM
Immunome Inc.
Sale(S)Indirect62.3K shares at avg. $26.23$1.6M - Aug 10, 2026IMNM
Immunome Inc.
Sale(S)Indirect10.1K shares at avg. $26.07$264K - Aug 7, 2026IMNM
Immunome Inc.
Sale(S)Indirect15.2K shares at avg. $26.06$397K - Aug 6, 2026IMNM
Immunome Inc.
Sale(S)Indirect20.8K shares at avg. $26.06$543K - Jul 7, 2026IMNM
Immunome Inc.
Sale(S)Indirect16.9K shares at avg. $24.20$409K - Jul 6, 2026IMNM
Immunome Inc.
Sale(S)Indirect83.1K shares at avg. $24.11$2.0M - Jul 2, 2026IMNM
Immunome Inc.
Sale(S)Indirect24.3K shares at avg. $23.33$568K - Jul 2, 2026IMNM
Immunome Inc.
Sale(S)Indirect75.7K shares at avg. $22.35$1.7M - Jun 30, 2026IMNM
Immunome Inc.
Sale(S)Indirect101.1K shares at avg. $21.12$2.1M - Jun 10, 2026IMNM
Immunome Inc.
Award(A)DirectDirector Stock Option (right to buy)
9.9K shares- - Dec 22, 2025IMNM
Immunome Inc.
Sale(S)Indirect371.9K shares at avg. $21.72$8.1M - Dec 22, 2025IMNM
Immunome Inc.
Sale(S)Indirect11.3K shares at avg. $22.34$251K - Jun 10, 2025IMNM
Immunome Inc.
Award(A)DirectDirector Stock Option (right to buy)
18.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | IMNM Immunome Inc. | Sale(S) | 11,048 | $27.25 | $301,058 | Direct |
| Aug 11, 2026 | IMNM Immunome Inc. | Sale(S) | 62,291 | $26.23 | $1,633,893 | Indirect |
| Aug 10, 2026 | IMNM Immunome Inc. | Sale(S) | 10,125 | $26.07 | $263,959 | Indirect |
| Aug 7, 2026 | IMNM Immunome Inc. | Sale(S) | 15,248 | $26.06 | $397,363 | Indirect |
| Aug 6, 2026 | IMNM Immunome Inc. | Sale(S) | 20,840 | $26.06 | $543,090 | Indirect |
| Jul 7, 2026 | IMNM Immunome Inc. | Sale(S) | 16,906 | $24.20 | $409,125 | Indirect |
| Jul 6, 2026 | IMNM Immunome Inc. | Sale(S) | 83,094 | $24.11 | $2,003,396 | Indirect |
| Jul 2, 2026 | IMNM Immunome Inc. | Sale(S) | 24,335 | $23.33 | $567,736 | Indirect |
| Jul 2, 2026 | IMNM Immunome Inc. | Sale(S) | 75,665 | $22.35 | $1,691,113 | Indirect |
| Jun 30, 2026 | IMNM Immunome Inc. | Sale(S) | 101,050 | $21.12 | $2,134,176 | Indirect |
| Jun 10, 2026 | IMNM Immunome Inc. | Award(A) Director Stock Option (right to buy) | 9,897 | - | - | Direct |
| Dec 22, 2025 | IMNM Immunome Inc. | Sale(S) | 371,949 | $21.72 | $8,078,732 | Indirect |
| Dec 22, 2025 | IMNM Immunome Inc. | Sale(S) | 11,251 | $22.34 | $251,347 | Indirect |
| Jun 10, 2025 | IMNM Immunome Inc. | Award(A) Director Stock Option (right to buy) | 18,864 | - | - | Direct |
1-14 of 14 transactions
About Barchas Isaac
Barchas Isaac (SEC CIK 0001808343) files insider reports with the SEC as Director of Immunome Inc. (IMNM).
Signal8 holds 7 ownership filings by Barchas Isaac, all Form 4s, filed between Jun 12, 2025 and Aug 12, 2026. Those filings report 14 transactions, from Jun 10, 2025 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Barchas Isaac's filings is in BOTHELL, WA.
Recent filings by Barchas Isaac
- Aug 12, 2026: Open-market sale of IMNM shares (Form 4, code S).
- Aug 11, 2026: Open-market sale of IMNM shares (Form 4, code S).
- Aug 10, 2026: Open-market sale of IMNM shares (Form 4, code S).
- Aug 7, 2026: Open-market sale of IMNM shares (Form 4, code S).
- Aug 6, 2026: Open-market sale of IMNM shares (Form 4, code S).
Other insiders filing for Immunome Inc. (IMNM)
- Higgins Jack, Chief Scientific Officer
- Horn Kinney, CHIEF BUSINESS OFFICER
- Tsai Philip, Chief Technical Officer
- Stoneman Sandra G., CHIEF LEGAL OFFICER & GC
- Rosett Max, Chief Financial Officer
- Lechleider Robert, Chief Medical Officer